Institutional Investors Increase Stakes in Elicio Therapeutics
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
What happened
Institutional investors have recently increased their positions in shares of Elicio Therapeutics, Inc. reports that Renaissance Technologies LLC grew its stake in the company by 332.7% during the first quarter. Additionally, BlackRock Inc. bought a new stake in Elicio Therapeutics during the second quarter, and Deutsche Bank AG also acquired a new stake during the second quarter, according to.
From themarketsdaily.com
Why it matters
The increased investment activity by major financial firms suggests growing institutional confidence in Elicio Therapeutics, Inc. This capital movement could influence market demand and the valuation of the company's stock.
From themarketsdaily.com
Who's involved
- Renaissance TechnologiesAmerican hedge fund firm that grew its investment stake in Elicio Therapeutics, Inc.
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- Renaissance TechnologiesSpeculative
Renaissance Technologies LLC might see changes in the cost of investment or returns on its portfolio.
Keep exploring
The entities involved
-
Renaissance Technologies
American hedge fund firm
Related events
- BlackRock, OMERS, Renaissance Technologies, and Bank of America increased their stakes in Paramount Gold Nevada Corp. stock on November 1, 2026.
- Renaissance Technologies raised its stake in shares of Star Equity Holdings, Inc. on August 25, 2026.
- Multiple major financial institutions, including Renaissance Technologies and BlackRock, increased their holdings in Coherus Oncology stock on October 31, 2026.
- Renaissance Technologies raised its position in U.S. Global Investors on October 17, 2026.
- Renaissance Technologies purchased a new stake in MIND C.T.I., a company listed on the Nasdaq exchange.